E. Hachulla and D. Launay, Diagnosis and classification of systemic sclerosis, Clin Rev Allergy Immunol, vol.40, issue.2, pp.78-83, 2011.

V. D. Steen and T. A. Medsger, Changes in causes of death in systemic sclerosis, Ann Rheum Dis, vol.66, issue.7, pp.940-944, 1972.

A. J. Tyndall, B. Bannert, M. Vonk, P. Airo, F. Cozzi et al., Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Annals of the rheumatic diseases, vol.69, pp.1809-1824, 2010.

A. U. Wells, P. Cullinan, D. M. Hansell, M. B. Rubens, C. M. Black et al., Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis, Am J Respir Crit Care Med, vol.149, issue.6, pp.1583-90, 1994.

D. Launay, M. Remy-jardin, U. Michon-pasturel, I. Mastora, E. Hachulla et al., High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis, J Rheumatol, vol.33, issue.9, pp.1789-801, 2006.

D. P. Tashkin, R. Elashoff, P. J. Clements, J. Goldin, M. D. Roth et al., Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med, vol.354, issue.25, pp.2655-66, 2006.

R. K. Hoyles, R. W. Ellis, J. Wellsbury, B. Lees, P. Newlands et al., A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma, Arthritis Rheum, vol.54, issue.12, pp.3962-70, 2006.

A. U. Wells, V. Steen, and G. Valentini, Pulmonary complications: one of the most challenging complications of systemic sclerosis, Rheumatology (Oxford), vol.48, issue.3, pp.40-44, 2009.

A. U. Wells, Interstitial lung disease in systemic sclerosis, Presse Med, vol.43, pp.320-363, 2014.

D. Launay, A. L. Buchdahl, A. Berezne, P. Y. Hatron, E. Hachulla et al., Mycophenolate mofetil following cyclophosphamide in worsening systemic sclerosis-associated interstitial lung disease, Journal of Scleroderma, 2016.

N. S. Goh, S. R. Desai, S. Veeraraghavan, D. M. Hansell, S. J. Copley et al., Interstitial lung disease in systemic sclerosis: a simple staging system, Am J Respir Crit Care Med, vol.177, issue.11, pp.1248-54, 2008.

O. A. Moore, N. Goh, T. Corte, H. Rouse, O. Hennessy et al., Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease, Rheumatology (Oxford), vol.52, issue.1, pp.155-60, 2013.

H. Brown and R. Prescott, Applied Mixed Models in Medicine. Sons JW, editor, 1999.

, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum, vol.23, pp.581-90, 1980.

E. C. Leroy and T. A. Medsger, Criteria for the classification of early systemic sclerosis, The Journal of rheumatology, vol.28, issue.7, pp.1573-1579, 2001.

, Lung function in SSc-associated ILD

. Plos-one-|, , 2017.

J. Wanger, J. L. Clausen, A. Coates, O. F. Pedersen, V. Brusasco et al., Standardisation of the measurement of lung volumes. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology, vol.26, pp.511-533, 2005.

N. Macintyre, R. O. Crapo, G. Viegi, D. C. Johnson, C. P. Van-der-grinten et al., Standardisation of the single-breath determination of carbon monoxide uptake in the lung. The European respiratory journal: official journal of the European Society for, Clinical Respiratory Physiology, vol.26, issue.4, pp.720-755, 2005.

G. Verbeke and G. Molenberghs, Linear Mixed Models for Longitudinal Data, pp.55-76, 2000.

D. Khanna, C. H. Tseng, N. Farmani, V. Steen, D. E. Furst et al., Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group, Arthritis and rheumatism, vol.63, issue.10, pp.3078-85, 2011.

O. A. Moore, S. M. Proudman, N. Goh, T. J. Corte, H. Rouse et al., Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease, Clin Exp Rheumatol, vol.33, issue.4, pp.111-117, 2015.

C. E. Mcculloch, H. Lin, E. H. Slate, and B. W. Turnbull, Discovering subpopulation structure with latent class mixed models, Stat Med, vol.21, issue.3, pp.417-446, 2002.

D. Bouros, A. U. Wells, A. G. Nicholson, T. V. Colby, V. Polychronopoulos et al., Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome, Am J Respir Crit Care Med, vol.165, issue.12, pp.1581-1587, 2002.

A. Man, T. Davidyock, L. T. Ferguson, M. Ieong, Y. Zhang et al., Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling, Rheumatology (Oxford), vol.54, issue.8, pp.1464-71, 2015.

N. S. Goh, R. K. Hoyles, C. P. Denton, D. M. Hansell, E. A. Renzoni et al., Short term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis, pp.2326-5205

S. Alivernini, D. Santis, M. Tolusso, B. Mannocci, A. Bosello et al., Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing, J Am Acad Dermatol, vol.60, issue.3, pp.426-461, 2009.

C. Mihai, R. Landewe, D. Van-der-heijde, U. A. Walker, P. I. Constantin et al., Digital ulcers predict a worse disease course in patients with systemic sclerosis, Ann Rheum Dis, 2015.

I. Silva, J. Almeida, and C. Vasconcelos, A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients, Autoimmun Rev, vol.14, pp.140-52, 2015.

I. Castellvi, C. P. Simeon-aznar, M. Sarmiento, A. Fortuna, M. Mayos et al., Association Between Nailfold Capillaroscopy Findings and Pulmonary Function Tests in Patients with Systemic Sclerosis, J Rheumatol, 2014.

V. D. Steen, G. Graham, C. Conte, G. Owens, and T. A. Medsger, Isolated diffusing capacity reduction in systemic sclerosis, Arthritis Rheum, vol.35, issue.7, pp.765-70, 1992.

A. M. Stupi, V. D. Steen, G. R. Owens, E. L. Barnes, G. P. Rodnan et al., Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arthritis Rheum, vol.29, issue.4, pp.515-539, 1986.

P. J. Clements, M. D. Roth, R. Elashoff, D. P. Tashkin, J. Goldin et al., Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis, Ann Rheum Dis, vol.66, issue.12, pp.1641-1648, 2007.